The first three-part of the Keeping up with the Chemos podcast series focused on tisotumab vedotin, and now this second installment series focuses on lenvatinib/pembrolizumab, which highlights some general information on lenvatinib/pembrolizumab including mechanism of clinical indications for prescribing. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologist and Ophthalmologist/Optometrist educated and prepared for giving lenvatinib/pembrolizumab. The session wraps up with some key take home points on lenvatinib/pembrolizumab. 2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith Smith, PharmDSpeakers:Jennifer MacDonald, PharmD, BCOPPamela Soliman, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.